IPSC
NASDAQ · Biotechnology
Century Therapeutics Inc
$1.67
+0.00 (+0.00%)
Open$1.66
Previous Close$1.67
Day High$1.72
Day Low$1.62
52W High$3.04
52W Low$0.44
Volume—
Avg Volume586.1K
Market Cap306.02M
P/E Ratio—
EPS$-0.90
SectorBiotechnology
Analyst Ratings
Strong Buy
12 analysts
Price Target
+1,537.7% upside
Current
$1.67
$1.67
Target
$27.35
$27.35
$22.03
$27.35 avg
$42.34
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 219.29M | 24.41M | 24.82M |
| Net Income | -19,247,792 | -1,389,193 | -1,166,783 |
| Profit Margin | -8.8% | -5.7% | -4.7% |
| EBITDA | -8,380,701 | -1,777,503 | -1,974,923 |
| Free Cash Flow | — | -1,484,406 | -1,631,995 |
| Rev Growth | +175.9% | +22.2% | +16.0% |
| Debt/Equity | — | 0.27 | 0.31 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $266.28 | +0.73% | 74.3 | 468.50B |
| AMGN | Amgen Inc | $418.13 | +0.85% | 25.1 | 219.78B |
| GILD | Gilead Sciences Inc | $152.21 | +0.85% | — | 185.02B |
| VRTX | Vertex Pharmaceuticals Inc | $527.67 | +0.28% | 30.5 | 134.17B |
| REGN | Regeneron Pharmaceuticals | $752.25 | -4.54% | 18.8 | 81.31B |
| ALNY | Alnylam Pharmaceuticals Inc | $255.36 | -0.23% | 41.4 | 33.44B |